End-term Evaluation of the Global Fund’s COVID-19 Response Mechanism and Its Contribution to the Strengthening of Sustainable Health Systems and Pandemic Preparedness
24 October 2025
The end-term evaluation of the Global Fund’s COVID-19 Response Mechanism (C19RM) will assess how C19RM has contributed to building resilient health systems and pandemic preparedness. The evaluation will examine effectiveness, coherence and sustainability, and balance accountability with learning.
Findings from this evaluation will guide the 2026-2028 Grant Cycle 8 (GC8) and post-2028 strategy. The insights will also support future pandemic preparedness and inform decisions by the Global Fund Board, Secretariat, and Strategy Committee, and partners such as the World Health Organization, Gavi, governments, nongovernmental organizations, and other organizations.
The specific objectives are:
- To summarize and assess the contribution of C19RM – alongside the roles of other partners – to the achievement of intended intermediate outcomes of the response mechanism (see Theory of Change) with a focus on the five strategic priorities (effectiveness).
- To assess the alignment and complementarity of C19RM with a specific focus on the collaboration with country governments, other partners and Global Fund Grant Cycle 7 RSSH investments (external and internal coherence).
- To assess the extent to which C19RM contributed/is contributing to the transition, maintenance, adaptation and/or national integration of supported interventions (differentiated by strategic priority) and thereby strengthened conditions for sustainability.
The evaluation’s target audiences will include:
- The Strategy Committee;
- The Global Fund Board;
- The Global Fund Secretariat;
- Key technical and implementation partners;
- National governments (e.g., Ministries of Health);
- Principal Recipients (PRs), Sub-Recipients (SRs);
- Nongovernmental Organizations (NGOs) and Civil Society Organizations (CSOs);
- United Nations agencies and other international organizations.
The final report is expected in November 2026.